Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Arcturus Therapeutics Holdings Inc. (ARCT)

9.68 -1.35 (-12.28%)
As of 2:52:30 PM EST. Market Open.
Trade ARCT on Coinbase
Chart Range Bar
Loading chart for ARCT
  • Previous Close 11.03
  • Open 11.00
  • Bid 4.43 x 200
  • Ask 7.96 x 200
  • Day's Range 9.62 - 11.05
  • 52 Week Range 5.50 - 17.96
  • Volume 452,865
  • Avg. Volume 992,007
  • Market Cap (intraday) 274.993M
  • Beta (5Y Monthly) 2.61
  • PE Ratio (TTM) --
  • EPS (TTM) -3.33
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 23.80
  • Zacks Rating Bullish

Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In addition, it develops KOSTAIVE, a self-amplifying RNA vaccine for COVID-19; ARCT-2138 (LUNAR-FLU), which is in Phase1 clinical trial for the treatment of seasonal influenza; and ARCT-2304 (LUNAR-H5N1) that is in Phase1 clinical trial for the treatment of Pandemic Influenza. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.

arcturusrx.com

106

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ARCT
57.83%
S&P 500 (^GSPC)
10.52%

1-Year Return

ARCT
2.96%
S&P 500 (^GSPC)
10.60%

3-Year Return

ARCT
48.01%
S&P 500 (^GSPC)
75.21%

5-Year Return

ARCT
79.24%
S&P 500 (^GSPC)
63.38%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 2.96M
Earnings -23.79M
Profit Margin -803.82%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-20M
-10M
0
10M
-1200.0%
-1000.0%
-800.0%
-600.0%
-400.0%
-200.0%

Analyst Insights

View More

Analyst Price Targets

9.00
23.80 Average
9.68 Current
41.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/9/2026
Analyst Leerink Partners
Rating Action Maintains
Rating Outperform
Price Action Raises
Price Target 13 -> 19

Statistics

View More

Valuation Measures

Annual
As of 10/30/2026
  • Market Cap

    312.37M

  • Enterprise Value

    143.82M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    16.46

  • Price/Book (mrq)

    1.82

  • Enterprise Value/Revenue

    7.68

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -23.96%

  • Return on Equity (ttm)

    -46.31%

  • Revenue (ttm)

    29.37M

  • Net Income Avi to Common (ttm)

    -93.28M

  • Diluted EPS (ttm)

    -3.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    191.48M

  • Total Debt/Equity (mrq)

    13.35%

  • Levered Free Cash Flow (ttm)

    19.26M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

9.68 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 06/17/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 11/29/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 08/13/2021

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: